6 unknown, 5 completed, 2 recruiting, 1 active not recruiting. 4 Phase 2, 4 Phase 4, 3 Phase 3, 1 Early Phase 1, 1 Not applicable.
Follow Mirabegron 50 MG: new trials by email Literature Review of Mirabegron 50 MG trials Research Report on Mirabegron 50 MG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial Evaluating the Clinical Efficacy and Safety of Hibero SR (Mirabegron) 50 mg and Ditropan (Oxybutynin Chloride) 10 mg in Children Between 5 and 18 Years With Overactive Bladder (OAB) Mirabegron 50 MG, Oxybutynin Chloride 5 MG - Overactive Bladder | Phase 2 | Unknown | Seoul National University Hospital | 44 | 2024-04-01 | 2024-03-08 |
| Using Mirabegron to Increase BP in Patients With POTS Mirabegron 50 MG, Mirabegron 25 MG - Postural Orthostatic Tachycardia Syndrome, Chronic Orthostatic Intolerance | Phase 2 | Completed | Cedars-Sinai Medical Center | 20 | 2023-12-22 | 2026-04-08 |
| Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women Mirabegron 50 MG, Brief Behavioral Treatment for Insomnia - Urgency Urinary Incontinence, Nocturia | Phase 4 | Active not recruiting | Shachi Tyagi | 120 | 2023-03-05 | 2026-08-10 |
| THE EFFECTS OF MIRABEGRON AND TAMSULOSIN FOR PATIENTS WITH URETERAL STENTS Mirabegron 50 MG - Ureteral Stone, Kidney Stones | Phase 4 | Completed | Hasanuddin University | 42 | 2022-07-01 | 2023-11-13 |
| The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics Mirabegron 50 MG, Tadalafil 10 MG, Placebo - Pre-diabetes, Obesity | Phase 4 | Recruiting | Philip Kern | 96 | 2021-12-13 | 2026-08-31 |
| Efficacy of Mirabegron Versus Tamsulosin Versus Solifenacin for Treatment of Ureteral Stents-Related Symptoms Mirabegron 50 MG, Tamsulosin, Solifenacin Succinate 10 MG - Ureteral Stent, Stent Related Symptoms | Phase 3 | Unknown | Mansoura University | 240 | 2021-12-01 | 2021-11-23 |
| Posterior Tibial Nerve Stimulation (PTNS) Plus Mirabegron to Treat Refractory OAB Symptoms (PTNS-M Study) Mirabegron 50 MG, Posterior Tibial Nerve Stimulation (PTNS) - Overactive Bladder | Phase 4 | Completed | University of Alabama at Birmingham | 54 | 2021-10-01 | 2023-07-20 |
| Effect of beta3-adrenoceptor Agonist on Patients With Overactive Bladder and as a Urinary Biomarker Mirabegron 50 MG, Solifenacin Succinate 5 MG - Overactive Bladder Syndrome, Detrusor Overactivity | Unknown | Chang Gung Memorial Hospital | 400 | 2021-03-01 | 2021-01-27 | |
| Mechanisms for Activation of Beige Adipose Tissue in Humans Placebo, Mirabegron, Mirabegron 50 MG - PreDiabetes | Phase 2 | Recruiting | Philip Kern | 65 | 2020-12-07 | 2026-07-07 |
| Impact of Mirabegron on Erectile Function in BPH Patients Mirabegron 50 MG, Alpha Blockers - Males With Benign Prostatic Hyperplasia Symptoms | Unknown | Kasr El Aini Hospital | 100 | 2020-10-01 | 2020-08-10 | |
| Comparative Study Between Behavior Therapy and Behavior Therapy Plus Mirabegron in Sexually Active Men With OAB Symptoms Behavior therapy alone, Mirabegron 50 MG Extended Release Oral Tablet - Urinary Bladder, Overactive, Sexual Behavior | Not applicable | Completed | Chang Gung Memorial Hospital | 150 | 2020-06-05 | 2022-10-05 |
| Mirabegron And Ureteral Stent-related Pain (MAP) Trial Mirabegron 50 MG, Placebo oral tablet - Nephrolithiasis | Phase 3 | Unknown | Unity Health Toronto | 142 | 2020-02-03 | 2020-02-26 |
| Comparison of Solifenacin and Mirabegron in Treatment of Overactive Bladder Symptoms in Men After TURP Solifenacin 5Mg, Mirabegron 50 MG - Overactive Bladder Syndrome | Phase 2 | Unknown | Buddhist Tzu Chi General Hospital | 130 | 2018-08-01 | 2018-08-24 |
| Mirabegron in Achalasia: A Clinical and Manometric Proof of Concept Pilot Study Mirabegron 50 MG, Placebo - Achalasia | Early Phase 1 | Terminated | Thomas Jefferson University | 5 | 2018-02-15 | 2021-03-24 |
| A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin) mirabegron 25 mg, mirabegron 50 mg, solifenacin 5 mg - Urinary Bladder Diseases, Urinary Bladder Overactive | Phase 3 | Completed | Astellas Pharma Europe Ltd. | 2174 | 2013-07-10 | 2024-10-31 |
Urinary Bladder, Overactive (6) · Ureterolithiasis (2) · Diabetes Mellitus (1) · Esophageal Achalasia (1) · Glucose Intolerance (1) · Kidney Calculi (1) · Lower Urinary Tract Symptoms (1) · Nephrolithiasis (1) · Nocturia (1) · Obesity (1) · Platelet Glycoprotein IV Deficiency (1) · Postural Orthostatic Tachycardia Syndrome (1) · Prediabetic State (1) · Sexual Behavior (1) · Sexual Dysfunctions, Psychological (1)
Chang Gung Memorial Hospital (2) · Philip Kern (2) · Astellas Pharma Europe Ltd. (1) · Buddhist Tzu Chi General Hospital (1) · Cedars-Sinai Medical Center (1) · Hasanuddin University (1) · Kasr El Aini Hospital (1) · Mansoura University (1) · Seoul National University Hospital (1) · Shachi Tyagi (1) · Thomas Jefferson University (1) · Unity Health Toronto (1) · University of Alabama at Birmingham (1)
United States (7) · Canada (2) · Taiwan (2) · Armenia (1) · Australia (1) · Austria (1) · Belgium (1) · Czechia (1) · Denmark (1) · Egypt (1) · Finland (1) · France (1) · Georgia (1) · Germany (1) · Greece (1)
Amr A Elsawy (1) · Hann-Chorng Kuo, M.D. (1) · Kwanjin Park, MD/PhD (1) · Michael Ordon, MD, FRCSC (1) · Muhammad A Palinrungi (1) · Philip Kern, M.D. (1) · Philip Kern, MD (1) · Russell F Stanley, DO (1) · Shachi Tyagi, MD (1) · Tsang-Tang Hsieh, MD (1)
PMID 10027879, PMID 10188996, PMID 10797303, PMID 11176525, PMID 11412210, PMID 11857671, PMID 12007519, PMID 12579626, PMID 12579627, PMID 12811491, PMID 14693111, PMID 14973214, PMID 16406907, PMID 16753445, PMID 16813910, PMID 17010004, PMID 17574730, PMID 18311486, PMID 18423678, PMID 18565239, PMID 19089891, PMID 19220267, PMID 19254402, PMID 19281469, PMID 1939656, PMID 19816919, PMID 19889062, PMID 20132203, PMID 21371240, PMID 21501328, PMID 22258963, PMID 22310924, PMID 22531957, PMID 22588142, PMID 22981677, PMID 23452071, PMID 25130281, PMID 25369726, PMID 26310546, PMID 26965560, PMID 27092789, PMID 28102552, PMID 28916436, PMID 29140559, PMID 29556972, PMID 37160401, PMID 39101958
R01AG076575 (1), R01DK124626 (1), R01DK128033 (1)